Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence
- PMID: 2496145
- PMCID: PMC303866
- DOI: 10.1172/JCI114057
Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence
Abstract
The present study was designed to elucidate the molecular genetic basis of a familial deficiency of alpha 2-plasmin inhibitor (alpha 2PI). Southern blot hybridization analysis with human alpha 2PI cDNA and genomic DNA probes demonstrated no gross deletion or rearrangement of the gene. By sequencing all the coding exons and exon-intron boundaries of the gene of a homozygote, we identified a single cytidine nucleotide insertion in the exon coding for the carboxyl-terminal region. This frameshift mutation leads to an alteration and elongation of the carboxyl-terminal portion of the deduced amino acid sequence. Synthetic oligonucleotide probes confirmed this frameshift mutation in all the affected family members including both heterozygous parents. In a transient expression assay, the alpha 2PI level in the culture medium of the cells transfected with the mutated alpha 2PI expression vector was very low and only 4% of that of the cells transfected with the normal vector, although the transcript levels and the cellular contents of alpha 2PIs did not differ significantly. Elongation of amino acid sequence in the mutant alpha 2PI was confirmed by an analysis of alpha 2PI in a transient expression experiment. These data indicate that this mutation is the cause of alpha 2PI deficiency in this pedigree.
Similar articles
-
A single thymine nucleotide deletion responsible for congenital deficiency of plasmin inhibitor.Thromb Haemost. 2002 Jul;88(1):144-8. Thromb Haemost. 2002. PMID: 12152655
-
Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.J Clin Invest. 1989 Apr;83(4):1144-52. doi: 10.1172/JCI113994. J Clin Invest. 1989. PMID: 2539391 Free PMC article.
-
Characterization and targeting of the murine alpha2-antiplasmin gene.Thromb Haemost. 1997 Sep;78(3):1104-10. Thromb Haemost. 1997. PMID: 9308761
-
Molecular genetics of alpha 2 plasmin inhibitor.Adv Exp Med Biol. 1990;281:195-200. doi: 10.1007/978-1-4615-3806-6_19. Adv Exp Med Biol. 1990. PMID: 2102612 Review.
-
Antithrombin III Kumamoto: identification of a point mutation and genotype analysis of the family.Thromb Haemost. 1990 Apr 12;63(2):231-4. Thromb Haemost. 1990. PMID: 2194315 Review.
Cited by
-
The plasmin-antiplasmin system: structural and functional aspects.Cell Mol Life Sci. 2011 Mar;68(5):785-801. doi: 10.1007/s00018-010-0566-5. Epub 2010 Dec 7. Cell Mol Life Sci. 2011. PMID: 21136135 Free PMC article. Review.
-
Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117 (GGT----GGAG).Am J Hum Genet. 1990 May;46(5):934-42. Am J Hum Genet. 1990. PMID: 2339692 Free PMC article.
-
Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele.Hum Genet. 1990 Jul;85(2):195-9. doi: 10.1007/BF00193195. Hum Genet. 1990. PMID: 2370048
-
New nucleotide sequence data on the EMBL File Server.Nucleic Acids Res. 1989 Sep 25;17(18):7553-78. doi: 10.1093/nar/17.18.7553. Nucleic Acids Res. 1989. PMID: 2798119 Free PMC article. No abstract available.
-
Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.Mol Med. 1997 Jun;3(6):385-96. Mol Med. 1997. PMID: 9234243 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources